Recent Company News

• 10:15 AM ET Jul 06, 2026
  

  StreetAccount Summary - Private company transactions for the week ended 04-Jul

• 02:07 AM ET Jul 02, 2026
  

  PureTech Health's Celea Therapeutics Inc. completes $180M financing (132.0000p, 0)

• 06:42 AM ET Jun 30, 2026
  

  StreetAccount Summary - European unusual volume traders

• 07:05 AM ET Jun 08, 2026
  

  Seaport Therapeutics reports multiple-ascending dose data from phase 1 proof-of-concept trial of GlyphAgo in healthy volunteers ($16.44, 0.00)

• 07:07 AM ET May 13, 2026
  

  PureTech Health to present Deupirfenidone IPF data at ATS 2026 conference (131.0000p, +1)

• 04:26 AM ET Apr 29, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 10:35 AM ET Apr 29, 2026
  

  Transcript Intelligence: PureTech Health Q4 Earnings Themes

• 10:35 AM ET Apr 29, 2026
  

  Transcript Intelligence: PureTech Health Q4 Earnings Guidance

• 10:34 AM ET Apr 29, 2026
  

  Transcript Intelligence: PureTech Health Q4 Earnings Q&A